🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The objective of this study is to determine the efficacy and safety of imat...
Status
Completed
Location
Multiple Locations
Start Date
2003-10
Trial ID
NCT00154349
Treatments Being Tested
Maintain and monitor long-term hematological and cytogenetic responses prev...
Status
Completed
Location
Novartis Investigative Site
Start Date
2008-08
Trial ID
NCT00786812
Treatments Being Tested
RATIONALE: STI571 may interfere with the growth of cancer cells and may be ...
Status
Completed
Location
Novartis Pharmaceuticals Corporation
Start Date
2000-06
Trial ID
NCT00006053
Treatments Being Tested
This is a multicenter, retrospective, observational study to validate a pha...
Status
Completed
Location
Princess Margaret Hospital, University of Toronto
Start Date
2011-09
Trial ID
NCT01437202
Open-labeled, multicenter, phase I/II study of imatinib combined with ESHAP...
Status
Unknown
Location
Dong-A University Hospital
Start Date
2015-02
Trial ID
NCT02431403
Treatments Being Tested
The purpose of this prospective, single-institution observational study is ...
Status
Completed
Location
UNC Hospital
Start Date
2019-06-20
Trial ID
NCT03885830
To characterize pharmacokinetic profile of test product compared to that of...
Status
Completed
Location
Kailash Cancer Hospital & Research Centre
Start Date
2014-02
Trial ID
NCT02103322
Treatments Being Tested
RATIONALE: Giving low doses of chemotherapy, such as fludarabine, and total...
Status
Terminated
Location
OHSU Knight Cancer Institute
Start Date
2003-05
Trial ID
NCT00416884
Treatments Being Tested
This pilot clinical trial studies the feasibility of choosing treatment bas...
Status
Completed
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2015-09-11
Trial ID
NCT02551718
RATIONALE: Imatinib mesylate may stop the growth of tumor cells by blocking...
Status
Completed
Location
Flinders Medical Centre
Start Date
2004-12
Trial ID
NCT00103168
Treatments Being Tested